Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Pleural Effusion 1Lung Neoplasms 1Hematologic Neoplasms 1Adjuvant Chemotherapy 1

Interventions

Thoracoscopy 4vandetanib 2Povidone-Iodine 2Cisplatin 2dalotuzumab 1X-Rays 1Ultrasonography 1Tyrosine Kinase Inhibitors 1Tissue Plasminogen Activator 1Thoracentesis 1Tenecteplase 1Surgical Procedures, Operative 1Saline Solution 1Receptors, Vascular Endothelial Growth Factor 1Pleurodesis 1Pemetrexed 1Octreotide 1Naproxen 1Hyperthermic Intraperitoneal Chemotherapy 1Gemcitabine 1Fentanyl 1Diclofenac 1Deoxyribonucleases 1Dasatinib 1Darbepoetin alfa 1Clinical Laboratory Techniques 1Chest Tubes 1Cdc25C phosphatase (211-221) 1Catheters, Indwelling 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Effusion × Tissue Plasminogen Activator × Clear all
NCT03678090 2020-03-05

The Safety and Efficacy of Fibrinolysis in Patients With an Indwelling Pleural Catheter for Multi-loculated Malignant Pleural Effusion.

Yale University

Phase 2 Withdrawn
Thoracic

Lung Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡